{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:28:24Z","timestamp":1791325704213,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T00:00:00Z","timestamp":1215561600000},"content-version":"vor","delay-in-days":3418,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1086\/302275","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T14:47:41Z","timestamp":1027694861000},"page":"722-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 Gene"],"prefix":"10.1016","volume":"64","author":[{"given":"Patricia L.","family":"Tavormina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Bellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie K.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Bamshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Fraley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinny","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethylin W.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair A.","family":"Francomano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1086\/302275_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1096-8628(19970627)70:4<427::AID-AJMG18>3.0.CO;2-J","article-title":"Long-term survival in typical type 1 thanatophoric dysplasia","volume":"70","author":"Baker","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1086\/302275_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(08)60305-X","article-title":"The FGF family of growth factors and oncogenes","volume":"59","author":"Basilico","year":"1992","journal-title":"Adv Cancer Res"},{"key":"10.1086\/302275_bib7","first-page":"A326","article-title":"Mutational analysis of FGFR3 in thanatophoric dysplasia, type I","volume":"61","author":"Bellus","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1086\/302275_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng1096-174","article-title":"Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes","volume":"14","author":"Bellus","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib4","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1086\/302275_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1749-6632.1996.tb56257.x","article-title":"Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene","volume":"785","author":"Bellus","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1086\/302275_bib8","first-page":"2745","article-title":"High-efficiency transfer of mammalian cells by plasmid DNA","volume":"7","author":"Chen","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1086\/302275_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1086\/302275_bib11","first-page":"24","article-title":"Two probable cases of homozygosity for the achondroplasia gene","volume":"5","author":"Hall","year":"1969","journal-title":"Birth Defects OAS"},{"key":"10.1086\/302275_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00685248","article-title":"Neuropathologic findings in thanatophoric dysplasia","volume":"63","author":"Ho","year":"1984","journal-title":"Acta Neuropathol"},{"key":"10.1086\/302275_bib13","first-page":"1","article-title":"Structural and functional diversity in the FGF receptor multigene family","volume":"60","author":"Johnson","year":"1993","journal-title":"Adv Cancer Res"},{"key":"10.1086\/302275_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajmg.1320280521","article-title":"Thanatophoric dysplasia and cloverleaf skull","volume":"3","author":"Langer","year":"1987","journal-title":"Am J Med Genet Suppl"},{"key":"10.1086\/302275_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.1320330420","article-title":"Growth and development in thanatophoric dysplasia","volume":"33","author":"MacDonald","year":"1989","journal-title":"Am J Med Genet"},{"key":"10.1086\/302275_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmg.10.1.11","article-title":"Observations suggesting allelism of the achondroplasia and hypochondroplasia genes","volume":"10","author":"McKusick","year":"1973","journal-title":"J Med Genet"},{"key":"10.1086\/302275_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans","volume":"11","author":"Meyers","year":"1995","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction","volume":"16","author":"Mohammadi","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1086\/302275_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)80131-2","article-title":"Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism","volume":"86","author":"Mohammadi","year":"1996","journal-title":"Cell"},{"key":"10.1086\/302275_bib21","first-page":"555","article-title":"A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome","volume":"60","author":"Muenke","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1086\/302275_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib23","doi-asserted-by":"crossref","first-page":"25049","DOI":"10.1074\/jbc.271.40.25049","article-title":"Ligand-independent activation of fibroblast growth factor receptors by point mutation in the extracellular, transmembrane and kinase domains","volume":"271","author":"Neilson","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1086\/302275_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.1320590325","article-title":"Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (gly to cys transition at codon 375)","volume":"59","author":"Nishimura","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1086\/302275_bib25","first-page":"115","article-title":"Thanatophoric dysplasia of the straight-bone type (type 2)","volume":"2","author":"Norman","year":"1992","journal-title":"Clin Dysmorphol"},{"key":"10.1086\/302275_bib26","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/hmg\/4.11.2097","article-title":"A common FGFR3 mutation in hypochondroplasia","volume":"4","author":"Prinos","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1086\/302275_bib27","series-title":"McKusick's heritable disorders of connective tissue","first-page":"557","article-title":"Genetic disorders of the osseous skeleton","author":"Rimoin","year":"1993"},{"key":"10.1086\/302275_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor 3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1086\/302275_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type 1 (TD1)","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1086\/302275_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dwarfism type 1","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR-3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1086\/302275_bib33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0387-7604(85)80013-9","article-title":"Neuropathological and Golgi study on a case of thanatophoric dysplasia","volume":"7","author":"Shigematsu","year":"1985","journal-title":"Brain Dev"},{"key":"10.1086\/302275_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1086\/302275_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01954274","article-title":"A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia","volume":"154","author":"Superti-Furga","year":"1995","journal-title":"Europ J Pediat"},{"key":"10.1086\/302275_bib36","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1086\/302275_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I & II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"10.1086\/302275_bib37","first-page":"95","article-title":"Hypochondroplasia","volume":"122","author":"Walker","year":"1971","journal-title":"Am J Dis Child"},{"key":"10.1086\/302275_bib38","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II","volume":"16","author":"Webster","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1086\/302275_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane point mutation found in achondroplasia","volume":"15","author":"Webster","year":"1996","journal-title":"EMBO J"},{"key":"10.1086\/302275_bib40","first-page":"132","article-title":"Neuropathological findings in thanatophoric dysplasia","volume":"107","author":"Wongmongkolrit","year":"1983","journal-title":"Arch Pathol Lab Med"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707617091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707617091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:05:25Z","timestamp":1757574325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929707617091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0002929707617091"],"URL":"https:\/\/doi.org\/10.1086\/302275","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 Gene","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1086\/302275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}